Literature DB >> 31402113

Psoriasis biologics: a new era of choice.

Satveer K Mahil1, Catherine H Smith2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31402113     DOI： 10.1016/S0140-6736(19)31772-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  The association between biologic agents and the risk of cardiovascular events in patients with psoriasis and psoriatic arthritis: A protocol for a systematic review and meta-analysis.

Authors:  Jie Ma; Ning Liang; Jialiang Chen; Yanping Bai
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

2.  P. granatum Peel Polysaccharides Ameliorate Imiquimod-Induced Psoriasis-Like Dermatitis in Mice via Suppression of NF-κB and STAT3 Pathways.

Authors:  Haiming Chen; Cheng Wang; Bin Tang; Jingjie Yu; Yue Lu; Junhong Zhang; Yuhong Yan; Hao Deng; Ling Han; Shaoping Li; Chuanjian Lu
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

3.  Psoriasis Increased the Risk of Adverse Cardiovascular Outcomes: A New Systematic Review and Meta-Analysis of Cohort Study.

Authors:  Lu Liu; Saijin Cui; Meitong Liu; Xiangran Huo; Guoqiang Zhang; Na Wang
Journal:  Front Cardiovasc Med       Date:  2022-03-25

Review 4.  Plasmacytoid Dendritic Cells as a New Therapeutic Target for Autoimmune Pancreatitis and IgG4-Related Disease.

Authors:  Kosuke Minaga; Tomohiro Watanabe; Akane Hara; Tomoe Yoshikawa; Ken Kamata; Masatoshi Kudo
Journal:  Front Immunol       Date:  2021-07-23       Impact factor: 7.561
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.